AMBN

Papers on AMBN

1 paper1 new in 30 days

Monday, November 16

Diabetes, Obesity & Metabolism

Canagliflozin linked to urine protein shifts in kidney disease

After one year, 124 urinary proteins changed with canagliflozin compared with placebo in people with type 2 diabetes and chronic kidney disease.After one year, 124 urinary proteins changed with canagliflozin compared with placebo in people with type 2 diabetes and chronic kidney disease.

Open in figure viewerPowerPoint Proteins associated with canagliflozin treatment and their associated pathways.
Case-control · 337 peopleCanagliflozin